转移性阴茎敏感性前列腺癌的治疗景观:一篇综述
Margaret F Meagher1, Amirali Salmasi1, Tyler F Stewart2
1Department of Urology, University of California San Diego, La Jolla, CA, USA.
Research and reports in urology
|November 29, 2023
概括
转移性割敏感前列腺癌 (mCSPC) 的最佳一线治疗正在随着新疗法的发展而发展. 本综述探讨了最近的进展,重点关注mCSPC管理的三重疗法选择.
科学领域:
- 在瘤学瘤学.
- 医学治疗学 医学治疗学
背景情况:
- 转移性割敏感前列腺癌 (mCSPC) 的管理正在迅速发展.
- 传统的治疗方法包括雄激素剥夺疗法和多塞塔克塞尔.
- 新的药物如雄激素受体信号抑制剂已经出现.
研究的目的:
- 审查mCSPC系统治疗的最新进展.
- 专门研究三重疗法在mCSPC中的作用和扩展.
主要方法:
- 对最近的临床研究和治疗指南进行叙述性审查.
- 对一线mCSPC的全身治疗选择的分析.
主要成果:
- 对于mCSPC,可以使用多种治疗方式.
- 对mCSPC的最佳第一线治疗方法尚未完全确定.
- 三重疗法代表了最近进步的一个重要领域.
结论:
- 对于mCSPC的治疗环境是充满活力的.
- 需要进一步的研究来确定最佳的第一线策略,包括三重疗法.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


